Improving the lives of people with acute, rare and chronic disorders.
Chiesi USA is the U.S. affiliate of Chiesi Farmaceutici, S.p.A, a global R&D-focused pharmaceutical company located in Parma, Italy. We are a specialty pharmaceutical company committed to the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings.
As an organization, we have a strong track record of performance. This has allowed the company to grow quickly in terms of sales, people and product portfolio. With revenues exceeding $275 million in 2018, Chiesi USA has quickly established itself as a top producing affiliate in the Chiesi worldwide group.
Our primary focus is on people: the people we serve in the healthcare community; the people whose lives are touched by our products and services; and the people who work at Chiesi USA, as they strive to build their company, their family and their community.
Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused Healthcare group with more than 80 years of experience in the pharmaceutical industry. The privately owned company has a strong focus on research, development, production and the commercialization of innovative medicines in therapeutic areas that include: respiratory, cardiovascular, neonatology, and cystic fibrosis.
The Chiesi Group spans the globe, employing more than 5,300 people in 27 affiliates worldwide and sells its products in more than 80 countries.